Trial intelligence / Profile preview

Vivitrol for Cocaine and Alcohol Dependence

NCT00777062Phase 2Completed

Sponsor
University of Pennsylvania
Start
Jul 2009
Primary completion
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of naltrexone in cocaine dependence and alcohol dependence, sponsored by University of Pennsylvania. Primary endpoint: Urine Assay for Benzoylecgonine at 8 weeks. Started Jul 2009; status: completed.

02

Drugs

naltrexone
03

Conditions

cocaine dependencealcohol dependence

Beyond the preview

Go deeper on NCT00777062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00777062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call